Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Institution
- Keyword
-
- Kesintasan (2)
- Usia lanjut (2)
- *Alleles;; Arthritis (1)
- : Clavicle Fracture (1)
- ; immunogenicity (1)
-
- ;; Biomedical (1)
- ABPM (1)
- Acute abdomen;; diverticular disease;; stercoral colitis;; stercoral perforation (1)
- Acute myocardial injury; non-cardiac surgery (1)
- Acute/ drug therapy/mortality;; Male;; Middle Aged;; Multivariate Analysis;; Retrospective Studies;; Severity of Illness Index;; Survival Rate;; Treatment Outcome (1)
- Acute/ drug therapy;; Male (1)
- Adrenal Cortex Hormones/ therapeutic use;; Adult;; Drug-Induced Liver Injury/ drug therapy/mortality;; Female;; Hepatitis (1)
- Adrenal Cortex Hormones/ therapeutic use;; Drug-Induced Liver Injury/ drug therapy;; Female;; Hepatitis (1)
- Adult;; Alcohol Drinking/ prevention & control/psychology;; Female;; Follow-Up Studies;; Humans;; Infant (1)
- Africa (1)
- Africa; antiretroviral therapy; HIV/AIDS; resistance testing (1)
- Akt-1;; brain tumor;; cancer;; curcumin;; targeting;; NF-kappa B;; MALIGNANT GLIOMAS;; CANCER;; GROWTH;; PROTEINS;; Oncology (1)
- Alcohol;; liver fibrosis;; HIV;; hepatitis C;; FIB-4;; VETERANS AGING COHORT;; PLATELET RATIO INDEX;; PREDICTING LIVER FIBROSIS;; SUBSTANCE USE DISORDERS;; ASPARTATE-AMINOTRANSFERASE;; PSYCHIATRIC-DIAGNOSIS;; SAMPLING VARIABILITY;; CIRRHOSIS;; VALIDATION;; TESTS;; Immunology;; Infectious Diseases;; Microbiology (1)
- Alleles;; Animals;; Arthritis (1)
- Angiography and transcatheter embolization;; aortography;; colitis;; ischemic;; mesenteric artery ischemia (1)
- Angiosarcoma (1)
- Antibiotika (1)
- Antiretroviral therapy (1)
- Apixaban;; atrial fibrillation;; D-dimer;; risk assessment;; warfarin;; VENOUS THROMBOEMBOLISM;; STRATIFICATION SCHEMES;; COAGULATION ACTIVITY;; STROKE;; WARFARIN;; APIXABAN;; COHORT;; MARKERS;; DEATH;; RECLASSIFICATION;; Hematology;; Peripheral Vascular Disease (1)
- Apixaban;; bleeding;; dabigatran;; direct oral anticoagulant;; edoxaban;; management;; pharmacology;; rivaroxaban;; FACTOR-XA INHIBITOR;; NONVALVULAR ATRIAL-FIBRILLATION;; PROTHROMBIN;; COMPLEX CONCENTRATE;; SYMPTOMATIC VENOUS THROMBOEMBOLISM;; DIRECT THROMBIN;; INHIBITOR;; TOTAL KNEE ARTHROPLASTY;; ACUTE CORONARY SYNDROME;; TOTAL;; HIP-REPLACEMENT;; ACTIVATED FACTOR-VII;; LONG-TERM TREATMENT;; Cardiac & Cardiovascular Systems (1)
- Association;; rheumatoid arthritis;; SLC2A3;; GLUT3;; CNV;; COPY-NUMBER VARIATION;; SYSTEMIC-LUPUS-ERYTHEMATOSUS;; OIL-INDUCED;; ARTHRITIS;; RISK LOCUS;; SUSCEPTIBILITY;; GENOME;; ASSOCIATION;; DISEASE;; CHONDROCYTES;; POPULATION;; Genetics & Heredity (1)
- Aterosklerosis (1)
- Atrial fibrillation;; hemorrhage;; risk assessment;; stroke;; STRATIFICATION SCHEMES;; ISCHEMIC-STROKE;; ANTICOAGULATION;; VALIDATION;; Cardiac & Cardiovascular Systems;; Peripheral Vascular Disease (1)
- Autoimmune/ drug therapy/mortality;; Humans;; Liver Failure (1)
- Autoimmune/ drug therapy;; Humans;; Liver Failure (1)
- Publication
- Publication Type
Articles 91 - 94 of 94
Full-Text Articles in Internal Medicine
Prevalence And Clinical Characteristics Of Venous Thromboembolism At The Aga Khan University Hospital, Nairobi, Felix Mutuma Riunga
Prevalence And Clinical Characteristics Of Venous Thromboembolism At The Aga Khan University Hospital, Nairobi, Felix Mutuma Riunga
Master of Medicine in Internal Medicine
Aim: To determine the prevalence of venous thromboembolism in patients presenting to the Aga Khan University Hospital, Radiology Department for lower limb compression ultrasonography with doppler and CT pulmonary angiography. In those found to have venous thromboembolism, the distribution of risk factors as described by Wells, the pattern of clinical presentation, the pattern of initial therapy, the length of hospital stay, major bleeding episodes and in hospital mortality were described. Design: Prospective survey Background: Venous Thromboembolism is a major cause of morbidity and mortality worldwide and its occurrence locally, as well as its clinical characteristics needs to be described in …
A Gut Gone To Pot: A Case Of Cannabinoid Hyperemesis Syndrome Due To K2, A Synthetic Cannabinoid., Anene Ukaigwe, Paras Karmacharya, Anthony A. Donato
A Gut Gone To Pot: A Case Of Cannabinoid Hyperemesis Syndrome Due To K2, A Synthetic Cannabinoid., Anene Ukaigwe, Paras Karmacharya, Anthony A. Donato
Reading Hospital Internal Medicine Residency
Cannabinoid Hyperemesis Syndrome (CHS) was first described in 2004. Due to its novelty, CHS is often unrecognized by clinicians leading to expensive workup of these patients with cyclical symptoms. It may take up to 9 years to diagnose CHS. CHS is characterized by cyclical nausea and vomiting, abdominal pain, and an unusual compulsion to take hot showers in the presence of chronic use of cannabinoids. Cannabicyclohexanol is a synthetic cannabinoid, popularly known as K2 spice. It is a popular marijuana alternative among teenagers and young adults since it is readily available as herbal incense. Unlike marijuana, many users know that …
Nanotechnology And Its Implication In Medical Science, Syed Ahsan Ali, M. Tariq
Nanotechnology And Its Implication In Medical Science, Syed Ahsan Ali, M. Tariq
Department of Medicine
No abstract provided.
How Patients' Self-Disclosure About Sickle Cell Pain Episodes To Significant Others Relates To Living With Sickle Cell Disease, Valerian J. Derlega, Louis H. Janda, Jeannie Miranda, Ian A. Chen, B. Mitchell Goodman Iii, Wally Smith
How Patients' Self-Disclosure About Sickle Cell Pain Episodes To Significant Others Relates To Living With Sickle Cell Disease, Valerian J. Derlega, Louis H. Janda, Jeannie Miranda, Ian A. Chen, B. Mitchell Goodman Iii, Wally Smith
Psychology Faculty Publications
Objectives: This cross-sectional study examines to whom and how fully sickle cell disease (SCD) patients talk to others about sickle cell pain, how helpful it is to talk with others about these pain episodes, and the association between talking to others about sickle cell pain episodes and patients' psychological adjustment and coping strategies in managing the disease.
Methods: A convenience sample of 73 African American patients with SCD (30 men and 43 women), were recruited from two SCD clinics at the time of routine medical visits. Most participants had been diagnosed with hemoglobin SS, and they reported an average number …